CIK 0001762303
- Non-accelerated filer
- Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202578762
- Phone
- +1 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-22 | Holder Michael Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +37,500 | 37,500 | ||
| 2021-03-17 | Ekins Sean Sr. VP of Finance | Grant or award · Stock Options (Right to Buy) | +30,000 | 30,000 | ||
| 2021-03-04 | McGee Kathy M. Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +128,000 | 128,000 | ||
| 2020-11-17 | Ekins Sean Sr. VP of Finance | Grant or award | +5,000 | 5,000 | ||
| 2020-09-16 | PERRY MICHAEL S Chief Executive Officer | Sale | −9,000 | $27.41 | $247K | 425,087 |
| 2020-09-15 | PERRY MICHAEL S Chief Executive Officer | Sale | −23,769 | $27.23 | $647K | 434,087 |
| 2020-09-14 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +68,504 | 472,948 | ||
| 2020-09-14 | PERRY MICHAEL S Chief Executive Officer | Sale | −15,092 | $26.99 | $407K | 457,856 |
| 2020-09-11 | PERRY MICHAEL S Chief Executive Officer | Sale | −20,000 | $26.02 | $520K | 404,444 |
| 2020-09-10 | PERRY MICHAEL S Chief Executive Officer | Sale | −7,128 | $26.26 | $187K | 424,444 |
| 2020-09-09 | Liberto Erin Chief Commercial Officer | Grant or award · Stock Options (Right to Buy) | +6,000 | 24,000 | ||
| 2020-09-09 | Quick Andrew Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +4,038 | 16,150 | ||
| 2020-09-09 | Shiroma Donna General Counsel | Grant or award · Stock Options (Right to Buy) | +4,400 | 8,600 | ||
| 2020-09-09 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +83,333 | 431,572 | ||
| 2020-09-09 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +25,000 | 150,000 | ||
| 2020-07-17 | McIntyre David Chief Financial Officer | Purchase | +393 | $22.70 | $9K | 893 |
| 2020-07-16 | McIntyre David Chief Financial Officer | Purchase | +300 | $23.85 | $7K | 500 |
Page 11 of 11 · 217 trades